# Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

> **NCT01950351** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 241 (actual)

## Conditions studied

- Stage I Prostate Adenocarcinoma AJCC v7
- Stage II Prostate Adenocarcinoma AJCC v7

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **RADIATION:** Proton Beam Radiation Therapy
- **OTHER:** Quality-of-Life Assessment

## Key facts

- **NCT ID:** NCT01950351
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-10-10
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950351, "Hypofractionated Proton Beam Therapy for Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01950351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*